Cargando…
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)
MicroRNA (miRNA or miR) therapeutics in cancer are based on targeting or mimicking miRNAs involved in cancer onset, progression, angiogenesis, epithelial-mesenchymal transition and metastasis. Several studies conclusively have demonstrated that miRNAs are deeply involved in tumor onset and progressi...
Autores principales: | GAMBARI, ROBERTO, BROGNARA, ELEONORA, SPANDIDOS, DEMETRIOS A., FABBRI, ENRICA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902075/ https://www.ncbi.nlm.nih.gov/pubmed/27175518 http://dx.doi.org/10.3892/ijo.2016.3503 |
Ejemplares similares
-
Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2021) -
Which statistical significance test best detects oncomiRNAs in cancer tissues? An exploratory analysis
por: Tang, Wei, et al.
Publicado: (2016) -
Targeting pre-miRNA by Peptide Nucleic Acids: A new strategy to interfere in the miRNA maturation
por: Avitabile, Concetta, et al.
Publicado: (2012) -
The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015) -
HDAC inhibitor misprocesses bantam oncomiRNA, but stimulates hid induced apoptotic pathway
por: Bhadra, Utpal, et al.
Publicado: (2015)